SHORT COMMUNICATION
KEYWORDS
ABSTRACT
Reactive arthritis is an acute, sterile arthritis caused by infection, most commonly of the genitourinary system, respiratory tract or gastrointestinal tract. Most often it is the result of Chlamydia trachomatis, Yersinia, or Salmonella infections. Treatment depends on the disease form. In the acute form of infection, treatment is applied with antibiotics and no steroidal anti-inflammatory drugs. In the chronic form of disease, disease-modifying drugs (sulfasalazine or methotrexate) and corticosteroids should be used. In cases refractory to conventional therapy, one should consider the implementation of biological treatment (e.g., etanercept, or adalimumab) (Fig. 1–3, Table I).
REFERENCES (4)
1.
Kim PS, Klausmeier TL, Orr DP. Reactive arthritis: a review. J Adolesc Health 2009; 44: 309-315.
2.
Sieper J, Rudwaleit M, Braun J, van der Heijde D. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 2002; 46: 319-327.
3.
Kisiel B, Raczkiewicz A. Reaktywne zapalenie stawów. Zeszyt Reumatologiczny 2012 (w druku).
4.
Braun J, Kingsley G. van der Heijden D, et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4 th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6,1999. J Rheumatol 2000; 27: 2185-2192.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.